The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 5 , Pages 1163-1170, May 2007

Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model

  • Beat H. Walpoth, MD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
    • Corresponding Author InformationBeat H. Walpoth, MD, Clinic of Cardiovascular Surgery, University Hospital Geneva, 1211 Geneva 14, Switzerland
  • ,
  • Prisca Zammaretti, PhD

      Affiliations

    • Institute for Biomedical Engineering and Department of Materials Science, Swiss Federal Institute of Technology Zurich and University of Zurich, Switzerland
    • Prisca Zammaretti and Mustafa Cikirikcioglu contributed equally to this article.
  • ,
  • Mustafa Cikirikcioglu, MD, PhD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
    • Prisca Zammaretti and Mustafa Cikirikcioglu contributed equally to this article.
  • ,
  • Ebrahim Khabiri, MD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
  • ,
  • M. Karim Djebaili, MD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
  • ,
  • Jean-Claude Pache, MD

      Affiliations

    • Department of Clinical Pathology, University of Geneva, Switzerland
  • ,
  • Jean-Christophe Tille, MD, PhD

      Affiliations

    • Department of Clinical Pathology, University of Geneva, Switzerland
  • ,
  • Yacine Aggoun, MD

      Affiliations

    • Department of Anaesthesiology Research, University of Geneva, Switzerland
  • ,
  • Denis Morel, MD

      Affiliations

    • Division of Pediatric Cardiology, University Hospital of Geneva, Switzerland
  • ,
  • Afksendiyos Kalangos, MD, PhD

      Affiliations

    • Clinic of Cardiovascular Surgery, University of Geneva, Switzerland
  • ,
  • Jeffrey A. Hubbell, PhD

      Affiliations

    • Institute for Biomedical Engineering and Department of Materials Science, Swiss Federal Institute of Technology Zurich and University of Zurich, Switzerland
    • Institute of Bioengineering, Swiss Federal Institute of Technology, Lausanne, Switzerland
  • ,
  • Andreas H. Zisch, PhD

      Affiliations

    • Institute for Biomedical Engineering and Department of Materials Science, Swiss Federal Institute of Technology Zurich and University of Zurich, Switzerland
    • Department of Obstetrics, University Hospital of Zurich, Switzerland
    • Center for Integrative Human Physiology of the University of Zurich, Switzerland.
    • Corresponding Author InformationAddress for reprints: Andreas Zisch, PhD, Department of Obstetrics, University Hospital Zurich, Frauenklinikstr. 10, 8091 Zurich, Switzerland

Received 31 May 2006; received in revised form 24 August 2006; accepted 19 September 2006.

Objective

Intimal hyperplasia and surface thrombogenicity are major factors in the high failure rate of synthetic small-diameter bypass grafts. Vascular endothelial growth factor is a potent stimulus for endothelial growth, and its provision in a fibrin matrix coating at the luminal graft surface may hold a key to spontaneous graft endothelialization and improved graft patency.

Methods

Pigs underwent bilateral carotid artery interposition of expanded polytetrafluoroethylene grafts either impregnated with fibrin (n = 11)—engineered to locally release vascular endothelial growth factor121 (vascular endothelial growth factor–fibrin; n = 11)—or left uncoated (n = 12). Graft patency was assessed by quantitative carotid angiography followed by graft histomorphometry at the 1-month experimental end point.

Results

Patency rates were not significantly different between study groups. Grafts coated with fibrin or vascular endothelial growth factor–fibrin exhibited significantly increased angiographic narrowing at the proximal anastomosis (for both P < .05 vs uncoated) and no difference at the distal anastomosis and the grafts’ middle. Histological analysis showed 80% to 90% endothelial coverage and buildup of intima throughout the lengths of all grafts. Examination of the grafts’ midportion revealed significantly enlarged neointimal layers of smooth muscle actin-positive cells in grafts coated with vascular endothelial growth factor–fibrin (242 ± 47 μm2/μ) and fibrin (177 ± 41 μm2/μ), compared with uncoated grafts (131 ± 39 μm2/μ) (for both P < .05 vs uncoated). This thickening could not be explained by enhanced inflammation or vessel wall angiogenesis, which were minimal at the experimental end point.

Conclusions

Fibrin and vascular endothelial growth factor produced effects deleterious to graft healing, by increasing the narrowing at proximal anastomosis and neointimal growth beyond that seen in uncoated grafts. It may reflect direct activation by exogenous vascular endothelial growth factor of vascular smooth muscle cells.

CTSNet classification: 20, 35

Abbreviations and Acronyms: ePTFE, expanded polytetrafluoroethylene, SEM, scanning electron microscopy, TBS, tris-buffered saline, VEGF, vascular endothelial growth factor

 

 The study was supported by grants of the Swiss National Science Foundation and the Swiss Heart Foundation to B. H. W., the Gebert Ruef Foundation to A. H. Z. and J. A. H., and the European Union FP6-project Heart Repair.

PII: S0022-5223(07)00217-6

doi:10.1016/j.jtcvs.2007.01.029

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 5 , Pages 1163-1170, May 2007